Long-term management of moderate-to-severe adult atopic dermatitis: A consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Association of Italian Territorial and Hospital Allergists and Immunologists (AAIITO), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA), and the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC)

Antonio Costanzo, Paolo Amerio, Riccardo Asero, Andrea Chiricozzi, Monica Corazza, Antonio Cristaudo, Francesco Cusano, Silvia M. Ferrucci, Eustachio Nettis, Annalisa Patrizi, Cataldo Patruno, Ketty Peris, Mario Picozza, Luca Stingeni, Giampiero Girolomoni

Research output: Contribution to journalArticle

Abstract

Atopic dermatitis (AD) is a common chronic-relapsing inflammatory skin disease, burdened by various comorbidities. AD most commonly occurs in children but may persist or present in adulthood becoming a lifelong condition. Therefore, AD requires an effective long-term treatment improving disease signs and symptoms but also of patients' quality of life (QoL). However continuous long-term use of most traditional AD immunosuppressive treatments is not recommended for safety reasons or insufficient efficacy data. Despite the available guidelines, there is still need for knowledge of AD long-term treatment, taking into account new disease measures and recent treatment options. Five Italian scientific societies implemented a joint consensus procedure to define the most appropriate clinical practice for the long-term management of adult moderate-severe AD. Through a modified Delphi procedure, consensus was reached by overall 51 Italian dermatologists and allergists (The Italian AD Study Group) experienced in the management of adult AD on 14 statements covering three AD areas of interest, namely diagnosis, definition of disease severity and clinimetrics, and a treat-to-target approach. This paper reports and discusses the agreed statements, which define disease and patient impact measures, therapeutic approach, and a treatment decision algorithm to support clinicians in the long-term management of adult patients with moderate-to-severe AD in their daily clinical practice.
Original languageEnglish
Pages (from-to)1-12
Number of pages12
JournalItalian Journal of Dermatology and Venereology
Volume157
DOIs
Publication statusPublished - 2022

Keywords

  • Adult
  • Allergists
  • Asthma
  • Biological products
  • Child
  • Consensus
  • Dermatitis, Atopic
  • Dermatitis, atopic
  • Dermatologists
  • Dermatology
  • Diagnosis
  • Dupilumab
  • Hospitals
  • Humans
  • Quality of Life
  • Venereology

Fingerprint

Dive into the research topics of 'Long-term management of moderate-to-severe adult atopic dermatitis: A consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Association of Italian Territorial and Hospital Allergists and Immunologists (AAIITO), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA), and the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC)'. Together they form a unique fingerprint.

Cite this